ID   KPCL_HUMAN              Reviewed;         683 AA.
AC   P24723; B4DJN5; Q16246; Q8NE03;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 4.
DT   12-OCT-2022, entry version 216.
DE   RecName: Full=Protein kinase C eta type;
DE            EC=2.7.11.13 {ECO:0000269|PubMed:34593629};
DE   AltName: Full=PKC-L;
DE   AltName: Full=nPKC-eta;
GN   Name=PRKCH; Synonyms=PKCL, PRKCL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=1986216; DOI=10.1128/mcb.11.1.126-133.1991;
RA   Bacher N., Zisman Y., Berent E., Livneh E.;
RT   "Isolation and characterization of PKC-L, a new member of the protein
RT   kinase C-related gene family specifically expressed in lung, skin, and
RT   heart.";
RL   Mol. Cell. Biol. 11:126-133(1991).
RN   [2]
RP   ERRATUM OF PUBMED:1986216, AND SEQUENCE REVISION.
RX   PubMed=1545821; DOI=10.1128/mcb.12.3.1404-.1992;
RA   Bacher N., Zisman Y., Berent E., Livneh E.;
RL   Mol. Cell. Biol. 12:1404-1404(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 438-539 (ISOFORM 1).
RX   PubMed=7988719; DOI=10.1016/0014-5793(94)01202-4;
RA   Palmer R.H., Ridden J., Parker P.J.;
RT   "Identification of multiple, novel, protein kinase C-related gene
RT   products.";
RL   FEBS Lett. 356:5-8(1994).
RN   [8]
RP   FUNCTION.
RX   PubMed=11112424; DOI=10.1006/bbrc.2000.3903;
RA   Akkaraju G.R., Basu A.;
RT   "Overexpression of protein kinase C-eta attenuates caspase activation and
RT   tumor necrosis factor-alpha-induced cell death.";
RL   Biochem. Biophys. Res. Commun. 279:103-107(2000).
RN   [9]
RP   FUNCTION IN CELL PROLIFERATION.
RX   PubMed=10806212; DOI=10.1074/jbc.m003203200;
RA   Hussaini I.M., Karns L.R., Vinton G., Carpenter J.E., Redpath G.T.,
RA   Sando J.J., VandenBerg S.R.;
RT   "Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific
RT   proliferative response in astrocytic tumor cells.";
RL   J. Biol. Chem. 275:22348-22354(2000).
RN   [10]
RP   FUNCTION.
RX   PubMed=11772428; DOI=10.1093/neuonc/4.1.9;
RA   Hussaini I.M., Carpenter J.E., Redpath G.T., Sando J.J., Shaffrey M.E.,
RA   Vandenberg S.R.;
RT   "Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-
RT   induced apoptosis in glioblastoma cells by preventing caspase-9
RT   activation.";
RL   Neuro-oncol. 4:9-21(2002).
RN   [11]
RP   FUNCTION IN CELL PROLIFERATION.
RX   PubMed=15489897; DOI=10.1038/sj.onc.1208093;
RA   Aeder S.E., Martin P.M., Soh J.W., Hussaini I.M.;
RT   "PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR
RT   signaling pathways.";
RL   Oncogene 23:9062-9069(2004).
RN   [12]
RP   INTERACTION WITH DGKQ.
RX   PubMed=15632189; DOI=10.1074/jbc.m409301200;
RA   van Baal J., de Widt J., Divecha N., van Blitterswijk W.J.;
RT   "Translocation of diacylglycerol kinase theta from cytosol to plasma
RT   membrane in response to activation of G protein-coupled receptors and
RT   protein kinase C.";
RL   J. Biol. Chem. 280:9870-9878(2005).
RN   [13]
RP   FUNCTION.
RX   PubMed=17146445; DOI=10.1038/sj.onc.1210090;
RA   Uht R.M., Amos S., Martin P.M., Riggan A.E., Hussaini I.M.;
RT   "The protein kinase C-eta isoform induces proliferation in glioblastoma
RT   cell lines through an ERK/Elk-1 pathway.";
RL   Oncogene 26:2885-2893(2007).
RN   [14]
RP   FUNCTION IN B-CELL SIGNALING.
RX   PubMed=18780722; DOI=10.1093/intimm/dxn101;
RA   Oda A., Ono T., Yamamoto M., Goitsuka R., Kitamura D.;
RT   "PKC eta directs induction of IRF-4 expression and Ig kappa gene
RT   rearrangement in pre-BCR signaling pathway.";
RL   Int. Immunol. 20:1417-1426(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [16]
RP   INDUCTION.
RX   PubMed=19797084; DOI=10.1128/mcb.01044-09;
RA   Raveh-Amit H., Maissel A., Poller J., Marom L., Elroy-Stein O., Shapira M.,
RA   Livneh E.;
RT   "Translational control of protein kinase Ceta by two upstream open reading
RT   frames.";
RL   Mol. Cell. Biol. 29:6140-6148(2009).
RN   [17]
RP   FUNCTION IN PHOSPHORYLATION OF OCLN.
RX   PubMed=19114660; DOI=10.1073/pnas.0802741106;
RA   Suzuki T., Elias B.C., Seth A., Shen L., Turner J.R., Giorgianni F.,
RA   Desiderio D., Guntaka R., Rao R.;
RT   "PKC eta regulates occludin phosphorylation and epithelial tight junction
RT   integrity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:61-66(2009).
RN   [18]
RP   FUNCTION.
RX   PubMed=20558593; DOI=10.1124/mol.110.064394;
RA   Lee H.K., Yeo S., Kim J.S., Lee J.G., Bae Y.S., Lee C., Baek S.H.;
RT   "Protein kinase C-eta and phospholipase D2 pathway regulates foam cell
RT   formation via regulator of G protein signaling 2.";
RL   Mol. Pharmacol. 78:478-485(2010).
RN   [19]
RP   FUNCTION.
RX   PubMed=21820409; DOI=10.1016/j.bbrc.2011.07.090;
RA   Raveh-Amit H., Hai N., Rotem-Dai N., Shahaf G., Gopas J., Livneh E.;
RT   "Protein kinase C? activates NF-?B in response to camptothecin-induced DNA
RT   damage.";
RL   Biochem. Biophys. Res. Commun. 412:313-317(2011).
RN   [20]
RP   REVIEW.
RX   PubMed=12473186; DOI=10.1093/oxfordjournals.jbchem.a003297;
RA   Kashiwagi M., Ohba M., Chida K., Kuroki T.;
RT   "Protein kinase C eta (PKC eta): its involvement in keratinocyte
RT   differentiation.";
RL   J. Biochem. 132:853-857(2002).
RN   [21]
RP   FUNCTION.
RX   PubMed=22304920; DOI=10.1016/j.cell.2012.01.016;
RA   Lau E., Kluger H., Varsano T., Lee K., Scheffler I., Rimm D.L., Ideker T.,
RA   Ronai Z.A.;
RT   "PKCepsilon promotes oncogenic functions of ATF2 in the nucleus while
RT   blocking its apoptotic function at mitochondria.";
RL   Cell 148:543-555(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-656, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, INTERACTION WITH PRKCH UPSTREAM
RP   OPEN READING FRAME 2, AND PHOSPHORYLATION AT THR-656 AND SER-675.
RX   PubMed=34593629; DOI=10.1073/pnas.2018899118;
RA   Jayaram D.R., Frost S., Argov C., Liju V.B., Anto N.P., Muraleedharan A.,
RA   Ben-Ari A., Sinay R., Smoly I., Novoplansky O., Isakov N., Toiber D.,
RA   Keasar C., Elkabets M., Yeger-Lotem E., Livneh E.;
RT   "Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor
RT   of PKCs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-138, PHOSPHORYLATION AT SER-28
RP   AND SER-32, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16973127; DOI=10.1016/j.bbrc.2006.08.160;
RA   Littler D.R., Walker J.R., She Y.-M., Finerty P.J. Jr., Newman E.M.,
RA   Dhe-Paganon S.;
RT   "Structure of human protein kinase C eta (PKCeta) C2 domain and
RT   identification of phosphorylation sites.";
RL   Biochem. Biophys. Res. Commun. 349:1182-1189(2006).
RN   [26]
RP   ASSOCIATION OF VARIANT ILE-374 WITH ISCHSTR, AND CHARACTERIZATION OF
RP   VARIANT ILE-374.
RX   PubMed=17206144; DOI=10.1038/ng1945;
RA   Kubo M., Hata J., Ninomiya T., Matsuda K., Yonemoto K., Nakano T.,
RA   Matsushita T., Yamazaki K., Ohnishi Y., Saito S., Kitazono T., Ibayashi S.,
RA   Sueishi K., Iida M., Nakamura Y., Kiyohara Y.;
RT   "A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of
RT   cerebral infarction.";
RL   Nat. Genet. 39:212-217(2007).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-19; ARG-65; GLN-149; GLN-359; ILE-374;
RP   ALA-575; ILE-594 AND SER-612.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-
CC       dependent serine/threonine-protein kinase that is involved in the
CC       regulation of cell differentiation in keratinocytes and pre-B cell
CC       receptor, mediates regulation of epithelial tight junction integrity
CC       and foam cell formation, and is required for glioblastoma proliferation
CC       and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and
CC       activates the tyrosine kinase FYN, which in turn blocks epidermal
CC       growth factor receptor (EGFR) signaling and leads to keratinocyte
CC       growth arrest and differentiation. Associates with the cyclin CCNE1-
CC       CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1
CC       dephosphorylation and thereby G1 arrest in keratinocytes. In
CC       association with RALA activates actin depolymerization, which is
CC       necessary for keratinocyte differentiation. In the pre-B cell receptor
CC       signaling, functions downstream of BLNK by up-regulating IRF4, which in
CC       turn activates L chain gene rearrangement. Regulates epithelial tight
CC       junctions (TJs) by phosphorylating occludin (OCLN) on threonine
CC       residues, which is necessary for the assembly and maintenance of TJs.
CC       In association with PLD2 and via TLR4 signaling, is involved in
CC       lipopolysaccharide (LPS)-induced RGS2 down-regulation and foam cell
CC       formation. Upon PMA stimulation, mediates glioblastoma cell
CC       proliferation by activating the mTOR pathway, the PI3K/AKT pathway and
CC       the ERK1-dependent phosphorylation of ELK1. Involved in the protection
CC       of glioblastoma cells from irradiation-induced apoptosis by preventing
CC       caspase-9 activation. In camptothecin-treated MCF-7 cells, regulates
CC       NF-kappa-B upstream signaling by activating IKBKB, and confers
CC       protection against DNA damage-induced apoptosis. Promotes oncogenic
CC       functions of ATF2 in the nucleus while blocking its apoptotic function
CC       at mitochondria. Phosphorylates ATF2 which promotes its nuclear
CC       retention and transcriptional activity and negatively regulates its
CC       mitochondrial localization. {ECO:0000269|PubMed:10806212,
CC       ECO:0000269|PubMed:11112424, ECO:0000269|PubMed:11772428,
CC       ECO:0000269|PubMed:15489897, ECO:0000269|PubMed:17146445,
CC       ECO:0000269|PubMed:18780722, ECO:0000269|PubMed:19114660,
CC       ECO:0000269|PubMed:20558593, ECO:0000269|PubMed:21820409,
CC       ECO:0000269|PubMed:22304920}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13;
CC         Evidence={ECO:0000269|PubMed:34593629};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.13; Evidence={ECO:0000269|PubMed:34593629};
CC   -!- ACTIVITY REGULATION: Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are
CC       calcium-insensitive, but activated by diacylglycerol (DAG) and
CC       phosphatidylserine. Three specific sites; Thr-513 (activation loop of
CC       the kinase domain), Thr-656 (turn motif) and Ser-675 (hydrophobic
CC       region), need to be phosphorylated for its full activation. Inhibited
CC       by PRKCH upstream open reading frame 2 (PubMed:34593629).
CC       {ECO:0000269|PubMed:34593629}.
CC   -!- SUBUNIT: Interacts with FYN (By similarity). Interacts with RALA (By
CC       similarity). Interacts with DGKQ (PubMed:15632189). Interacts with
CC       PRKCH upstream open reading frame 2; the interaction leads to
CC       inhibition of kinase activity (PubMed:34593629).
CC       {ECO:0000250|UniProtKB:P23298, ECO:0000269|PubMed:15632189,
CC       ECO:0000269|PubMed:34593629}.
CC   -!- INTERACTION:
CC       P24723; Q16625-1: OCLN; NbExp=2; IntAct=EBI-2865850, EBI-16115673;
CC       P24723; Q28269: OCLN; Xeno; NbExp=2; IntAct=EBI-2865850, EBI-16222162;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24723-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24723-2; Sequence=VSP_056572;
CC   -!- TISSUE SPECIFICITY: Most abundant in lung, less in heart and skin.
CC       {ECO:0000269|PubMed:1986216}.
CC   -!- INDUCTION: By stress conditions caused by amino acid starvation (at
CC       protein level). {ECO:0000269|PubMed:19797084}.
CC   -!- DOMAIN: The C1 domain, containing the phorbol ester/DAG-type region 1
CC       (C1A) and 2 (C1B), is the diacylglycerol sensor and the C2 domain is a
CC       non-calcium binding domain.
CC   -!- DISEASE: Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute
CC       neurologic event leading to death of neural tissue of the brain and
CC       resulting in loss of motor, sensory and/or cognitive function. Ischemic
CC       strokes, resulting from vascular occlusion, is considered to be a
CC       highly complex disease consisting of a group of heterogeneous disorders
CC       with multiple genetic and environmental risk factors.
CC       {ECO:0000269|PubMed:17206144}. Note=Disease susceptibility is
CC       associated with variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M55284; AAA60100.1; -; mRNA.
DR   EMBL; AK290183; BAF82872.1; -; mRNA.
DR   EMBL; AK296158; BAG58897.1; -; mRNA.
DR   EMBL; AL138996; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355916; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359220; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW80800.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW80801.1; -; Genomic_DNA.
DR   EMBL; BC037268; AAH37268.1; -; mRNA.
DR   EMBL; S74620; AAB32724.1; -; mRNA.
DR   CCDS; CCDS9752.1; -. [P24723-1]
DR   PIR; A39666; A39666.
DR   RefSeq; NP_006246.2; NM_006255.4. [P24723-1]
DR   RefSeq; XP_016876947.1; XM_017021458.1. [P24723-2]
DR   PDB; 2FK9; X-ray; 1.75 A; A=1-138.
DR   PDB; 3TXO; X-ray; 2.05 A; A=333-683.
DR   PDBsum; 2FK9; -.
DR   PDBsum; 3TXO; -.
DR   AlphaFoldDB; P24723; -.
DR   SMR; P24723; -.
DR   BioGRID; 111569; 24.
DR   DIP; DIP-44588N; -.
DR   IntAct; P24723; 12.
DR   MINT; P24723; -.
DR   STRING; 9606.ENSP00000329127; -.
DR   BindingDB; P24723; -.
DR   ChEMBL; CHEMBL3616; -.
DR   DrugCentral; P24723; -.
DR   GuidetoPHARMACOLOGY; 1487; -.
DR   iPTMnet; P24723; -.
DR   PhosphoSitePlus; P24723; -.
DR   BioMuta; PRKCH; -.
DR   DMDM; 281185512; -.
DR   EPD; P24723; -.
DR   jPOST; P24723; -.
DR   MassIVE; P24723; -.
DR   MaxQB; P24723; -.
DR   PaxDb; P24723; -.
DR   PeptideAtlas; P24723; -.
DR   PRIDE; P24723; -.
DR   ProteomicsDB; 4395; -.
DR   ProteomicsDB; 54223; -. [P24723-1]
DR   Antibodypedia; 24422; 283 antibodies from 32 providers.
DR   DNASU; 5583; -.
DR   Ensembl; ENST00000332981.11; ENSP00000329127.5; ENSG00000027075.17. [P24723-1]
DR   Ensembl; ENST00000555082.5; ENSP00000450981.1; ENSG00000027075.17. [P24723-2]
DR   GeneID; 5583; -.
DR   KEGG; hsa:5583; -.
DR   MANE-Select; ENST00000332981.11; ENSP00000329127.5; NM_006255.5; NP_006246.2.
DR   UCSC; uc001xfn.4; human. [P24723-1]
DR   CTD; 5583; -.
DR   DisGeNET; 5583; -.
DR   GeneCards; PRKCH; -.
DR   HGNC; HGNC:9403; PRKCH.
DR   HPA; ENSG00000027075; Low tissue specificity.
DR   MalaCards; PRKCH; -.
DR   MIM; 601367; phenotype.
DR   MIM; 605437; gene.
DR   neXtProt; NX_P24723; -.
DR   OpenTargets; ENSG00000027075; -.
DR   PharmGKB; PA33767; -.
DR   VEuPathDB; HostDB:ENSG00000027075; -.
DR   eggNOG; KOG0694; Eukaryota.
DR   GeneTree; ENSGT00940000158220; -.
DR   HOGENOM; CLU_000288_54_4_1; -.
DR   InParanoid; P24723; -.
DR   OMA; EFRHFSF; -.
DR   OrthoDB; 222529at2759; -.
DR   PhylomeDB; P24723; -.
DR   TreeFam; TF351133; -.
DR   BRENDA; 2.7.11.13; 2681.
DR   PathwayCommons; P24723; -.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   Reactome; R-HSA-418597; G alpha (z) signalling events.
DR   SABIO-RK; P24723; -.
DR   SignaLink; P24723; -.
DR   SIGNOR; P24723; -.
DR   BioGRID-ORCS; 5583; 12 hits in 1115 CRISPR screens.
DR   ChiTaRS; PRKCH; human.
DR   EvolutionaryTrace; P24723; -.
DR   GeneWiki; PRKCH; -.
DR   GenomeRNAi; 5583; -.
DR   Pharos; P24723; Tchem.
DR   PRO; PR:P24723; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; P24723; protein.
DR   Bgee; ENSG00000027075; Expressed in parotid gland and 187 other tissues.
DR   ExpressionAtlas; P24723; baseline and differential.
DR   Genevisible; P24723; HS.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004698; F:calcium-dependent protein kinase C activity; IEA:UniProtKB-EC.
DR   GO; GO:0004699; F:calcium-independent protein kinase C activity; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004697; F:protein kinase C activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0031267; F:small GTPase binding; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0050861; P:positive regulation of B cell receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045618; P:positive regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:1903078; P:positive regulation of protein localization to plasma membrane; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0070528; P:protein kinase C signaling; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; IMP:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00029; C1; 2.
DR   CDD; cd05590; STKc_nPKC_eta; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR034665; nPKC_eta.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027431; PKC_eta.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR014376; Prot_kin_PKC_delta.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000551; PKC_delta; 1.
DR   PIRSF; PIRSF501107; Protein_kin_C_eta; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   SUPFAM; SSF57889; SSF57889; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Differentiation; Kinase; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..683
FT                   /note="Protein kinase C eta type"
FT                   /id="PRO_0000055705"
FT   DOMAIN          1..118
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          355..614
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          615..683
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   ZN_FING         171..222
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         245..295
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          320..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        479
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         361..369
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         384
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         28
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000305|PubMed:16973127,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         32
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000305|PubMed:16973127"
FT   MOD_RES         317
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P23298"
FT   MOD_RES         513
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         656
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:34593629,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:34593629"
FT   VAR_SEQ         1..161
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056572"
FT   VARIANT         19
FT                   /note="A -> V (in dbSNP:rs55645551)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042312"
FT   VARIANT         65
FT                   /note="K -> R (in dbSNP:rs55737090)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042313"
FT   VARIANT         149
FT                   /note="R -> Q (in dbSNP:rs55848048)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042314"
FT   VARIANT         359
FT                   /note="R -> Q (in dbSNP:rs55818778)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042315"
FT   VARIANT         374
FT                   /note="V -> I (associated with susceptibility to ischemic
FT                   stroke; increases autophosphorylation and kinase activity;
FT                   dbSNP:rs2230500)"
FT                   /evidence="ECO:0000269|PubMed:17206144,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_034604"
FT   VARIANT         497
FT                   /note="D -> Y (in dbSNP:rs11846991)"
FT                   /id="VAR_060736"
FT   VARIANT         575
FT                   /note="T -> A (in a aLLTEL/AML1+ sample; somatic mutation;
FT                   dbSNP:rs1378993559)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042316"
FT   VARIANT         594
FT                   /note="T -> I (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042317"
FT   VARIANT         612
FT                   /note="P -> S (in dbSNP:rs34159231)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042318"
FT   VARIANT         645
FT                   /note="D -> V (in dbSNP:rs35561533)"
FT                   /id="VAR_042438"
FT   CONFLICT        96
FT                   /note="Missing (in Ref. 1; AAA60100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        109
FT                   /note="L -> R (in Ref. 1; AAA60100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110
FT                   /note="R -> G (in Ref. 1; AAA60100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        393
FT                   /note="Q -> L (in Ref. 1; AAA60100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        472
FT                   /note="D -> E (in Ref. 7; AAB32724)"
FT                   /evidence="ECO:0000305"
FT   STRAND          8..20
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   HELIX           26..30
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   TURN            31..33
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          34..37
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          43..49
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          52..56
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          67..79
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          81..88
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          91..94
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          96..104
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   HELIX           105..112
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          116..123
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          129..137
FT                   /evidence="ECO:0007829|PDB:2FK9"
FT   STRAND          355..364
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          367..374
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   TURN            375..377
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          380..387
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           388..394
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           397..409
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   TURN            410..412
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          419..424
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          426..434
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           441..448
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           453..472
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           482..484
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          485..487
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   STRAND          493..495
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           518..520
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           523..530
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           534..549
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           559..568
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           579..588
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           593..595
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           600..602
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           606..609
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           612..614
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           619..623
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           646..649
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           663..665
FT                   /evidence="ECO:0007829|PDB:3TXO"
FT   HELIX           668..671
FT                   /evidence="ECO:0007829|PDB:3TXO"
SQ   SEQUENCE   683 AA;  77828 MW;  0A29806CE31912F2 CRC64;
     MSSGTMKFNG YLRVRIGEAV GLQPTRWSLR HSLFKKGHQL LDPYLTVSVD QVRVGQTSTK
     QKTNKPTYNE EFCANVTDGG HLELAVFHET PLGYDHFVAN CTLQFQELLR TTGASDTFEG
     WVDLEPEGKV FVVITLTGSF TEATLQRDRI FKHFTRKRQR AMRRRVHQIN GHKFMATYLR
     QPTYCSHCRE FIWGVFGKQG YQCQVCTCVV HKRCHHLIVT ACTCQNNINK VDSKIAEQRF
     GINIPHKFSI HNYKVPTFCD HCGSLLWGIM RQGLQCKICK MNVHIRCQAN VAPNCGVNAV
     ELAKTLAGMG LQPGNISPTS KLVSRSTLRR QGKESSKEGN GIGVNSSNRL GIDNFEFIRV
     LGKGSFGKVM LARVKETGDL YAVKVLKKDV ILQDDDVECT MTEKRILSLA RNHPFLTQLF
     CCFQTPDRLF FVMEFVNGGD LMFHIQKSRR FDEARARFYA AEIISALMFL HDKGIIYRDL
     KLDNVLLDHE GHCKLADFGM CKEGICNGVT TATFCGTPDY IAPEILQEML YGPAVDWWAM
     GVLLYEMLCG HAPFEAENED DLFEAILNDE VVYPTWLHED ATGILKSFMT KNPTMRLGSL
     TQGGEHAILR HPFFKEIDWA QLNHRQIEPP FRPRIKSRED VSNFDPDFIK EEPVLTPIDE
     GHLPMINQDE FRNFSYVSPE LQP
//
